Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)-Reference-Cited by-同舟云学术

Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)

Published:2015-10-28 Issue:1 Volume:10 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Altoos Basel,Amini Arya,Yacoub Muthanna,Bourlon Maria T.,Kessler Elizabeth E.,Flaig Thomas W.,Fisher Christine M.,Kavanagh Brian D.,Lam Elaine T.,Karam Sana D.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-015-0528-z

Reference18 articles.

1. Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, et al. Local control rates of metastatic renal cell carcinoma (rcc) to the bone using stereotactic body radiation therapy: Is rcc truly radioresistant? Practical radiation oncology 2015. doi: 10.1016/j.prro.2015.05.004

2. Chen FH, Chiang CS, Wang CC, Tsai CS, Jung SM, Lee CC, et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in tramp-c1 prostate tumors. Clin Cancer Res. 2009;15:1721–9.

3. De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol. 2014;15:e170–7.

4. Escudier B, Pluzanska A, Koralewski P, Ravaud A, Bracarda S, Szcylik C, et al. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: A randomised, double-blind phase III trial. Lancet. 2007;370:2103–11.

5. Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii49–56.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR);Cancers;2024-08-25

2. Prognostic assessment of patients with bone metastatic renal cell cancer treated with palliative radiotherapy;Oncology Letters;2024-08-07

3. The role of radiation therapy for de novo metastatic bladder and renal cancers;Cancer/Radiothérapie;2024-02

4. Local Control in Patients with Metastatic Renal Cell Carcinoma to the Spine: The Experience of an Institution with a Multidisciplinary Spine Oncology Program;World Neurosurgery;2023-10

5. Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma;Endoscopy;2023-07-13